Medicine and Health

A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein

C. Kim, D. Ryu, et al.

Discover how the CT-P59 monoclonal antibody exhibits strong neutralization against SARS-CoV-2, including the D614G variant, with promising therapeutic effects demonstrated in animal models. This groundbreaking research was conducted by Cheolmin Kim, Dong-Kyun Ryu, Jihun Lee, and fellow authors.

00:00

Playback language: English

Related Publications

Explore these studies to deepen your understanding of the subject.

Medicine and Health

A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein

W. Pang, Y. Lu, et al.

Biology

Does the SARS-CoV-2 Spike Receptor-Binding Domain Hamper the Amyloid Transformation of Alpha-Synuclein after All?

Y. Stroylova, A. Konstantinova, et al.

Medicine and Health

Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda

D. L. Bugembe, M. V. T. Phan, et al.

Medicine and Health

A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants

Y. Du, R. Shi, et al.

Listen, Learn & Level Up

Over 10,000 hours of research content in 25+ fields, available in 12+ languages.

No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.

listen to research audio papers with researchbunny